首页> 外文期刊>Pediatric Pulmonology >Pulmonary Function and Fitness Years After Treatment for Hypersensitivity Pneumonitis During Childhood
【24h】

Pulmonary Function and Fitness Years After Treatment for Hypersensitivity Pneumonitis During Childhood

机译:儿童过敏性肺炎治疗后的肺功能和健身年限

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Hypersensitivity pneumonitis (HP) is an immune-mediated diffuse lung disease. Significant improvement in lung function and diffusing capacity after treatment was previously demonstrated, while long-term data focusing specifically on peripheral airway impairment and peak oxygen uptake (fitness) are lacking. Hence, the aim of this study was to conduct a comprehensive study to determine the stability of pulmonary function and fitness in patients previously diagnosed with HP. Methods: We performed a cross-sectional follow-up study with inclusion of longitudinal data if available in patients previously diagnosed with biopsy and high-resolution computed tomography-verified HP during childhood. We performed multiple breath wash-out (LCI2.5), spirometry (FEV1), bronchiodilator responsiveness test, diffusing capacity (DLCO and DLCO/V-A), body-plethysmography (TLC), and peak oxygen uptake (VO2peak). St. George Respiratory Questionnaire was used as a measure of respiratory quality of life. Results: Twenty two patients were assessed. LCI2.5 was abnormal in 47.4% compared to abnormal FEV1 in only 9.1% and without significant bronchiodilator responsiveness. DLCO and TLC were abnormal in 40.9 and 13.6%, respectively, while DLCO/V-A was within normal range. Only 11.1% demonstrated abnormal VO2peak. All longitudinally assessed outcomes remained unchanged between end of treatment and time of follow up. Conclusions: A large proportion of patients previously diagnosed with HP had abnormal LCI2.5 in contrast to normal spirometry. Spirometric outcomes, TLC, and diffusing capacity were persistently slightly reduced, but stable, and VO2peak was excellent at time of follow-up. Long-term prognosis in children with HP appears favorable although persistent peripheral airway involvement of unknown clinical significance was demonstrated in almost half of the patients. (C) 2015 Wiley Periodicals, Inc.
机译:背景:过敏性肺炎(HP)是一种免疫介导的弥漫性肺部疾病。先前已证明治疗后肺功能和扩散能力有显着改善,而缺乏专门针对周围气道损伤和峰值摄氧量(适应性)的长期数据。因此,本研究的目的是进行全面研究,以确定先前诊断为HP的患者的肺功能和健康状况的稳定性。方法:我们进行了一项横断面随访研究,包括纵向数据(如果有的话)用于以前被诊断为儿童的活检和高分辨率计算机断层扫描验证的儿童期。我们进行了多次呼吸冲洗(LCI2.5),肺活量测定(FEV1),支气管扩张剂反应性测试,扩散能力(DLCO和DLCO / V-A),体体积描记法(TLC)和峰值摄氧量(VO2peak)。圣乔治呼吸问卷被用来衡量呼吸生活质量。结果:评估了22例患者。 LCI2.5异常的比例为47.4%,而FEV1的异常比例仅为9.1%,并且没有明显的支气管扩张药反应性。 DLCO和TLC异常分别为40.9和13.6%,而DLCO / V-A在正常范围内。只有11.1%的人出现VO2peak异常。在治疗结束和随访时间之间,所有纵向评估的结果均保持不变。结论:与正常肺活量测定相比,以前被诊断为HP的患者中有很大一部分LCI2.5异常。肺活量结果,TLC和扩散能力持续略有降低,但稳定,随访时VO2peak极佳。尽管几乎一半的患者表现出持续的外周气道受累,但临床意义不明,但HP儿童的长期预后似乎良好。 (C)2015威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号